2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt | |
---|---|
Trade Name | |
Orphan Indication | Hepatocellular Carcinoma |
EU Market Approval | EU |
EU Designation Date | 2015-08-10 00:00:00 |
Sponsor | Dr Ulrich Granzer |